Lithuanian President Dalia Grybauskaitė thinks that problems regarding government-subsidized medicines have been "maliciously ignored" until now and that this issue will be a test of confidence for the country' new Health Minister Aurelijus Veryga.
Medicine
© DELFI / Karolina Pansevič

Daiva Ulbinaitė, the president's spokeswoman, said this to reporters after Grybauskaite met with the minister and representatives of supervisory authorities.

According to the spokeswoman, the Health Ministry has until now "maliciously ignored" this problem and there has been "an unjustified inaction".

Reducing medicines prices and increasing the transparency of the system will be "a test of confidence for the new minister", she said.

Also present at the meeting were Juratė Sovienė, deputy chairwoman of the Competition Council, and experts from the National Audit Office who have carried out an audit of the subsidized medicines system.

Įvertink šį straipnį
Norėdami tobulėti, suteikiame jums galimybę įvertinti skaitomą DELFI turinį.
  • 1
  • 2
  • 3
  • 4
  • 5
(0 žmonių įvertino)
0
Leave a comment
or for anonymous commenting click here
By posting, you agree to terms
Read comments Read comments

Lithuanians borrow less, but larger amounts and more responsibly

The Lithuanian non-bank financial sector is showing maturity: the consumer credit market survey of...

Crisis looks bigger through the eyes of fear, yet statistically insignificant

Last year, the rate of enterprise failure decreased by fivefold and credit ratings of companies...

Socially responsible business: growth opportunity or a rehabilitation centre for the disabled?

The Lithuanian Parliament (the Seimas) intends to oblige companies employing the disable d to...

A new co-working space UMA GO9 in downtown Vilnius will be filled with Nordic motifs of nature

On the top floor of a premium shopping center GO9 more than 2,000 square meters co-working space UMA...

FinTech companies showed avid interest in the LBChain project

The LBChain project has garnered significant attention among European FinTech companies: with 21...